It was recently announced that you will be presenting the upcoming Wallace H. Coulter Lecture at Pittcon 2018. What will be the main focus of your lecture??
Pittcon is an analytical conference, so naturally my talk will be about analytical chemistry and how analytical chemistry will become increasingly important in delivering healthcare solutions, not only for rich people, but also, hopefully, for poor people across the world.
The world faces many emergent medical threats and healthcare challenges. Professor Nicholsaon will discuss how precision medicine may offer more efficient and effective healthcare solutions in the 21st century. In an effort to achieve that objective, individual patient descriptions are required at the level of the genome, proteome, metabolome, or a combination of these aided by state-of-the-art technologies. High resolution analytical technologies and sophisticated computational modeling can create both new diagnostics and prognostics of disease ultimately leading to disease prevention in the future.
Meet Professor Jeremy Nicholson
Professor Nicholson obtained his PhD in Biochemistry from London University (1980). Appointed Full Professor of Chemistry, London University (1992) and Head of Biological Chemistry at Imperial College London (1998) then Head of the Department of Surgery and Cancer (2009) and Director of the UK National Phenome Centre (2012).
Nicholson has authored over 750 papers and articles on spectroscopy, informatics, metabolic biochemistry, and systems medicine. His major research focus is on the development of diagnostic and prognostic molecular phenotyping and computational technologies as applied to problems in personalised healthcare, microbiome-host metabolic signalling, metabolic diseases and cancer. He is a ISI Highly-Cited Researcher (H index =115) and has received numerous prizes including: Royal Society of Chemistry (RSC) Silver (1992) and Gold (1997) Medals for Analytical Chemistry; Chromatographic Society Jubilee Silver Medal (1994); Pfizer Prize for Chemical and Medicinal Technology (2002); RSC medal for Chemical Biology (2003); RSC Interdisciplinary Prize (2008); Pfizer Global Research Prize for Chemistry (2006) and the Semelweiss-Budapest International Prize for Biomedicine (2010). Elected Fellow of The UK Academy of Medical Sciences (2010); Honorary Lifetime Fellow of the International Metabolomics Society (2012); Honorary Lifetime Member of the US Society of Toxicology (2013); Albert Einstein Professor of the Chinese Academy of Sciences (2014).
Professor Nicholson holds honorary professorships including The Mayo Clinic, University of New South Wales, Australia, Nanyang Technological University (Singapore), Shanghai Jiao Tong University, Fudan University, the Chinese Academy of Sciences Dalian. He is a consultant for multiple pharmaceutical, healthcare and technology companies working in the area of metabolic phenotyping.